The Training and Development effort at Colgate-Palmolive is a direct outcome of the Individual Development Plan and the Business need. The business critical and individual specific needs are identified every year and a training needs inventory is drawn up.

Zydus Cadila is a professionally managed public company offering immense opportunities to learn and grow. This ability to evolve, gain new capabilities and raise the bar of excellence forms the heart of our success. We provide an environment where people come and give their best not because they have to, but because they want to. At Zydus we build people to build our business.

In an urge to provide quality pharma education online, PharmaTutor.org has decided to conduct an online competition focusing various pharma entrance exams such as GPAT, NIPER-JEE, CET, MAHE, Bits-exam, NMAT and others.

Meyer, an associate of London based multinational Vitabiotics Ltd.,is a rapidly growing Pharma Co. in India. Leading pharmaceutical manufacturer, founded in 1982 .,in technical collaboration with OMEGA-MEYER Ltd Jersey( Br. Isles). H.O. based in THANE

Post: Junior Executive

The National Dairy Development Board (NDDB) set up Indian Immunologicals Ltd. (IIL) in 1982 with the objective of making Foot and Mouth Disease (FMD) vaccine available to farmers at an affordable price. The technology for FMD vaccine manufacture was obtained from M/s. Wellcome Foundation Limited, United Kingdom. The plant in Hyderabad today has a capacity to make 80 million trivalent doses of FMD vaccine.

The Blood  Group Reference Centre (BGRC)  made its debut in 1957  as a result of active interest shown by Indian Council of Medical Research (ICMR)  in the field of blood banking.

About Authors: Divya Gupta,
M.Pharm (Pharmaceutics),
Dehradun Institute of Technology, Dehradun

Introduction
In the words of Hughes and Mitra2: “ophthalmic drug delivery is one of the most interesting and challenging endeavours facing the pharmaceutical scientist...The anatomy, physiology and biochemistry of the eye render this organ exquisitely impervious to foreign substances...The challenge to the formulator is to circumvent the protective barriers of the eye without causing permanent tissue damage...The primitive ophthalmic solutions, suspensions and ointment dosage forms are clearly no longer sufficient to combat some present virulent diseases...”

Eye is a unique and very valuable organ. This is considered a window hinge. We can enjoy it and look at the world body. There are many eye diseases that can affect the body and loss of vision as well. Therefore, many eyes in drug delivery systems are available. They are classified as traditional and new drug development system. Topical application of drugs to the eye is the most popular and well-accepted route of administration for the treatment of various eye disorders. The bioavailability of ophthalmic drugs is, however, very poor due to efficient protective mechanisms of the eye. Blinking, baseline and reflex lachrymation, and drainage remove rapidly foreign substances, including drugs, from the surface of the eye [1].

Troikaa mainly focuses on Novel Drug Delivery Systems (NDDS). The company firmly believes in providing superior therapeutic benefits by improvising the formulations through Innovative Technologies.
Six patents have been filed in various areas of drug delivery. To handle competition, Troikaa adopted various multifaceted strategies to help stand their ground in the competitive market. Another fact that helps us stand out is their high quality products.

Dr. Reddy's Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia.

June 2011

The Institute of Pharmacy has been established with a view to promote excellence in pharmaceutical education and to prepare young men and women to meet the challenges in the area of pharmaceutical industries, education, research and development and marketing. We aim to provide degree, postgraduate, doctoral and postdoctoral level education at this centre of excellence. The pharmacy profession in Gujarat and western part of India has been striving for such a centre and establishment of IP.

The history of Jamia Hamdard begins with the establishment of a small Unani clinic in the year 1906 by Hakeem Hafiz Abdul Majeed, one of the well-known practitioners of Unani System of Medicine of his time. Hakeem Hafiz Abdul Majeed had a vision of making the practice of Unani Medicine into a scientific discipline so that Unani medicines could be dispensed in a more efficacious manner to patients. He gave the name "Hamdard" to his venture which means "sympathy for all and sharing of pain".

About Authors:
DIPAK KUMAR DASH
M.PHARM, PHARMACEUTICS
HIMALAYAN PHARMACY INSTITUTE, SIKKIM

SUSPENSION
Pharmaceutical suspension may be defined as coarse dispersions in which insoluble solids are suspended in a liquid medium. Insoluble solids may have a size range from 10 to 1000 µm.

STABILITY OF SUSPENSION
It is important to understand that suspensions are kinetically stable, but thermodynamically unstable, system.
Physical stability is defined as the condition in which the particles remain uniformly distributed throughout the dispersion without any signs of sedimentation. It is difficult to achieve this condition. Hence the definition can be restated as –if the particles settle they should be easily resuspendable by moderate amount of shaking.

Pediatric Biology Center (PBC) conducts hypothesis driven research on the biological basis of childhood health and diseases. The generated knowledge will be incorporated in THSTI institutional networks developing diagnostic and therapeutic modalities.

Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.